[go: up one dir, main page]

PT2967138T - Método para tratar sepsies em pacientes com albumina, e níveis de colesterol e hdl acima de um limiar mínimo - Google Patents

Método para tratar sepsies em pacientes com albumina, e níveis de colesterol e hdl acima de um limiar mínimo Download PDF

Info

Publication number
PT2967138T
PT2967138T PT147108716T PT14710871T PT2967138T PT 2967138 T PT2967138 T PT 2967138T PT 147108716 T PT147108716 T PT 147108716T PT 14710871 T PT14710871 T PT 14710871T PT 2967138 T PT2967138 T PT 2967138T
Authority
PT
Portugal
Prior art keywords
cap cap
sap sap
ρρχ
ραρα
add add
Prior art date
Application number
PT147108716T
Other languages
English (en)
Inventor
Plojoux Julien
Greim Olivier
Zinovik Ihar
Jochnowitz Evan
Original Assignee
Philip Morris Products Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philip Morris Products Sa filed Critical Philip Morris Products Sa
Publication of PT2967138T publication Critical patent/PT2967138T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F47/00—Smokers' requisites not otherwise provided for
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/30—Devices using two or more structurally separated inhalable precursors, e.g. using two liquid precursors in two cartridges
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/40—Constructional details, e.g. connection of cartridges and battery parts
    • A24F40/42—Cartridges or containers for inhalable precursors
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/50—Control or monitoring
    • A24F40/51—Arrangement of sensors
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/50—Control or monitoring
    • A24F40/57—Temperature control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
    • A61M11/042—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0003—Details of inhalators; Constructional features thereof with means for dispensing more than one drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10—Devices using liquid inhalable precursors
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/40—Constructional details, e.g. connection of cartridges and battery parts
    • A24F40/46—Shape or structure of electric heating means
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/60—Devices with integrated user interfaces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
    • A61M11/047—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters by exothermic chemical reaction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0035—Piercing means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3368—Temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/36—General characteristics of the apparatus related to heating or cooling
    • A61M2205/364—General characteristics of the apparatus related to heating or cooling by chemical reaction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/36—General characteristics of the apparatus related to heating or cooling
    • A61M2205/3653—General characteristics of the apparatus related to heating or cooling by Joule effect, i.e. electric resistance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/82—Internal energy supply devices
    • A61M2205/8206—Internal energy supply devices battery-operated

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Catching Or Destruction (AREA)

Description

DESCRIÇÃO
MÉTODO PARA TRATAR BEPB1ES EM PACIENTES COM ALBUMINA, E NÍVEL DE COLESTEROL Si HDD ACIMA DE DM LXNIAR MÍNIMO
CAMPO DE INVENÇÃO EÇÇá XíSAAdp.ia SS:XA:dsas:A ád PsSPddSAPip. s!ã p:PdXASPSP: ADO As £ ISC dS SAPA 'ice' < 1AA::( A: Pax Pi: A P1 aAPAAXí X €>,, rSXlxA: iií As - AS: AS S AS A ΡΑχΑ-Ρα ds PidPpSpdXapAdP SsdApAapS d A .ΡΑΑΡΑρΧΑΑΑ. -Χρρ: ΧΝΧΑΑΑΐ dpsAs ASSSA:SAS:v
ANTECEDENTES E TÉCNICA ANTERIOR &amp;:;£:!:ÇAsÓ:C; ASA·' As X Αόρχ :Ρ·ρ::Χ.Ρ- .As X:Á Ρ;1ΑΧ(0ρΑ::. -dp: ·ρΑ;Α:ΡΑ::· .pp: SASSÀSS ppp ASíAí· ssCsAsiSSS^ AAr;0iSiA:SS:i:AiACs: PÇ PApSP: pÇpçpSp aA:pp::SAdp“ AS S ASSSSSÍA. SPXssXsA.l .-Αρρρρ· PA S.feA:t:AA· SE5 χΡΧ^ΡΡΧίΑΡ $P pASAppa iia^dSSApa'p SSAr PppSASrpa,*' 'ΧρΑΑ:.,· - ^ ' - íAl. f QaÍA:::^. :£;αα'Α ΧΐΑΑρ 37 :iÍ l:i;> ΙΑίΧΑ-ΡΧΙΙΧ (SapAl: f. :ÍPpSçpd:A:pdp v v ' ' ' ’ x ' A\ , s . í AXrXt > Cpsa- ÇepÇ JÁ: ;Γ:1.1 ΐ 333* $37 $3333} ·:.·, ‘AAAàPAi Í;dASAp:dÁpap: ÓSS ΑΡΡΡΑχρΡ.Ιρ; Mdiisdd ld í as ái:., r J XAÁspç"x M assísss^ 33Wi. -SÊÇ-dsd: 703337*. AsAâàdm :( ndASpASSXA d:d:d As:XXxss:Aa.S.-, SÁ ΡΑΡΑίΡΑ pSÇpAA::í A: ''(dSpSJsS'· AS-SAASAPA: A: |ίΡΑΑΡΑρΑ:: AS:- dia .SsA;pSA.AS· X P:£ !a:d<AÍxSXs. SAsssíSASA: PASiS: tàPAa; PA:, ΧαΡΡαρα
IdXAiasPAAá; - asa pap- ppp, sia íísssaaíp X:p!ps:as:Ap£:ía α;£α'ΑρΧμ:Αα. # d;s£;£d:dd:a. PípiAp A pXPÇAÇAp AP: d SP A P A CaXA:- ΑΡΡΑΡΑ-ΙάΡΑΡΑΑ- SP X X v ; : s , s * ' ' ' ; ΧχβΑρρρρρΑ pppddp AA: ? dçpSpIçÇ.çp :AS:S:p:ix'A:Ad:A:lA: ap.: PAp AAddAÇPAS:· -p pÇq pÇpjpSpÇ: ppÇSÇpI dS' v. 1 O' ' ; > í ' v “ s - = " * , ç . ps :paX:S psfXlps apsip íssáp XPadP ds apppspAa à; Jadssâp asíasa,:, pxspçAAp: S:dSA::í:P :,!idppçfçs; PSpA.XΑΡ''* :sPP d dssp:asd:X:pXdAPia Hd ;|:-ΑΡ;Α>®:Ρ:Χ X,X:dAdS: ΑΡΡΧΧαΡΑΡΑΑα,ΡΑ:,-. ΧΑ.ΡααΧΧϊΡΡ: :d.Àp,ΟΡρ-ΠΡΑΑ*. pSAdÉP ASAiA X Add l d- Mg dia SAPpS: AÍS A .XXlfAÇão PASia * ó PASSA: ^AfadjuP AíXppXpS ΡΑΑΑαα” PASApX SSpsipÀ: drspp: S APspAiA: sApAÀXA* Á:UAPdí> "SApAiAS’' A úAAdd Aqui,- tC-AdA AA PODCÍlÇÔe.A adli\A ASiAS sSSPSP X:ife:A: pSS - X d:APí, 1®: ®ta®®®aa®® Ο ΙΐΓ®!®®®®®®® ®:® ®:6®®®;®® Ixdiilidiiij. Ο®®®:® .a·! 1:® Sdidi':® it ® t:®®:®1ί;®:: a® 1. japi j/dida : Jpr®r®i®ad:®®®p:> ®:®Ρ 103®:® t®:® dip* d®®ajaçe®®®®;;®®: ® atdatppdcáo pedapít xp®.:. ^.S# ®®|®p; ifcap: a:®®a;d®:d®: % no oaso das eater®idast ator da a nas terapêuticas s®a ®a®®®P®e®®Í®::> US® p®sca;a®a pp®:®® ataixdeae®:®, ®;®®® ;d®®®xpa®®; a t, ρΐ^ tixOadÇ * a apta * afta ta* a ®px®a.i:idsdP ®®;st.i®si®: alto,,: a :;®·®®:: ®r®Xid® o:oooad::ttaíi|a: idldiea paxasa®:®®·® irrsat® sfeifeg·. d Bite®®® IM S: i’M; áditpda Pa®®:®®,, és il·,, oad/S: aittr:dfa::ál:áta itmaaxpetid®. pear ®e:i;e;xi®®ia pa®®®®®® ®®p;t®®®® da ®A:®Í®s sapa®®:®®®.;;. ® rarr#1 .ma®:®®®® eaxasaxa ao t®®®®®®®:®®; d® adddtPPi;®®;® < Pi® toástíot: d®?· a®®®;®®®®;· aadti®; ®m: aP®:f#a.Íp:|::do ISP®S®:S:X:da::ÍPar:Í:á:rraa ,- ®®®i ,t®;pld.fe: ®a®;®®t f:p®i® ilPaaittdmdsÇ o d® apt die pdpppp iieaiii®®': ;dp; pidica.,. Siri®®· x®:®.®®:® i®i Spt'Oiria.l® P®.: xdiâpãó Pp®: ®:dá: pàttoa ®pcr d®#e:;txta®:, ::ll: patente d€S:®x®®a pi® pxpppaaio ρρ;®® á. .pite®®:®®®®:® d® ®titit.dd®a tea add® aettddd para a ®®®. iaplilriidritat-tP· rirtxttá®®®®:':· ,ρρ. ρρ®ρρ®ρ: ®ρ® tit® .®.a®pi:;p tpapaiiatoiti ppippida ®a®e mepprdjpta® .foà; taaáatt: rpimptiò: ai ο®;®.®.®®®;®;. a® |®:p.tpn®a® -¾¾ dixltt®®®: a®® mpdipta®;®®! a, it®:® :®®®η ί,Ι-Χχί:·.
Id®:a®:|:iri:cit®x dpiSiS:aS:#S®:ir a eis :®® opp-ax® :®pi:pp.: ai f maPid® ®®ΙΡΡ®Ρ®: asa. '©i:il:irig®x: titPPii * maptan §:; p®®a,tp :d® dipli®® alia: mascam® pifasâpip.·,:. ® ®: a®;®ad.a .pTipida rail:a:tá;Ío por Dellinger et :·.' . , roa v ·'· '. a . ,· ·>.· a eMO-diti npo moppr®® aiiilaeaia ampapimr aa taaxaaiat:®: cam a® ptaodiP® > 'S®:xxaiio:®a~:s:eo apaipadsp pa®: a® ®®di®®a®. ta· tipo ίίρο®®·!®·® a® Pa®®® ta çeips a®: itaapo: ρ§®:: aixicppx®:; ®a®.px®a®d:drp;® a® tm. aáb:S®ai®a.aa da ®aaii#é:®a®:;f toma a:pat. claiàaiaa,:: i’iii xadmitido sâm; a®as a®: a® raap®'®®:®. d®:: 1|®®χ.®&amp;®®ό; aa® aa:t®d;dl;ç. aà® a® aa®!®®®®: ::®®á® |.®®:f:r®®.®a®i^ d«: taxai®;®®; .da®a® aiiica®®®;®: .a®r.a®a;®:®.a:daa ®a t®®®::®®.:®!® ®eti::li;®e:t®o:ii;®: t®:®®®®: te Baaiil®®;®®®· Fraraxada®. aa®. «®: ®a®:®a*
DESCRIÇÃO DS’ÍAD8&amp;S&amp; DAS FORMAS DE REALIZAÇÃO PREFER IDAS N '' ·. " . ' # .# ís p S5 .1. ®í # ft ftpftpft:35ftft .®'ã ##:#; iPfcP&amp;PeftdÁ·#:: da 1¾¾¾ ORAL &amp; ã:d#:d:ft: ftp ftfttft: dpli stç pftp· ftaftíptft^tlpe £3,}: ufe !'P®dp5t appftO.:,;· £:013 ft#;· .I:£;p:| ílo ft:ft;:ftp®'p· ft ft:1.1..1.¾ ®®p ppi ft5ft pM.ppftft d Çp ft:ftp£:Pt3lft®0: PftP apraaapft#:: #350:#ρ1#Ρ: :ft# :#ft£'P. {'’dydd' # ftft:pftft:;':| «" 3% M.pd:l. Pft pftpft: 5¾¾¾¾ .Li S ç/pli.í :S; :ftft; ftpftft:#: pft ftftftftftftpftftO.. ftp.tpft. Γ'Ρ50” ,3 seauir: Os·. paio i-enos 40 sç/dft ft· Llooprotai aa da a.lr.a ft!ft:ftftfta5ftp;ft ®05ί33®|:3!' a sappirf d;ar pai.#· ορ:#ρρ.>: #0. ρ#£®3:1,, Çft ::t:ftd3p Idlfttp pftft Ρρ;ΐΡ:#ίί; p.ft.ftftp: ftftftpl.p. ftp ftíftppftíftftpdftftpft aa>aa;s«:ã::t:ap: .l:£gK4òa:dloao::na ftpPipiftptp P- tftp: ftiftppftp' ftftpâft3..ftp ρρ.ΡΙ.όΐρΐΡ:#: pft.fta; .®ρρρΡ:Ρ0Ρ:ϊ: ft; ft®pp:.Pão # £ Ορρό a #ρ: Poplftafta pup .eFftftfttft· a PaPi:®#.®:.,: FPftftft:.# .a#: a ftftpaftftP: sstar PiftftPlft:doft # paPIpoftP: tPftPPa:i oft :.pdri:sai:t ftdft ftft3.1p.aa:dftft. fpft#;#: pftftOaPIdPft paPftc# fta:ft®dift ftPPo ftfti£:ftftftpftá:ft: pftftia; ftftftftftp®:; ftPfta# pftPft PftpftàPftlft· dá: PoP'ftPftP ft?Pa oftpftftftí.. .ρρρρ®.ft*p li. ftilpftpiiftft:. ft- lipftídidpiftlft pftld: ftitpftftlftft a- ftpft. pft.:ft:#:ft:ft£: IP##®# ftp SOpift· :β ftftlftftft.ftP pft:ft PalpO:# 3ft::ifttfteft' v ftftft aftpppift:,. ft:#. p#.4pft:# ®p:Pft:fft: ft# pl'Iftftfttftft .¾¾¾ Pftftft:pftft: critica? aatào raiacioa.ado# ft redução d# siaftasa hapéfticftp Ο® Cp tSpftft ftftCp P Ρ#ΡΡΡ#®®0θ. Ρ#ρ35ΐ«Ρ<. Iftft âap pft' .plpPl-ft ft# pXpçísifea. apapap çprsò: apa; lia:#:;##. tip paftip' .·#. PftpPftftftâa ft:#:pft:td:pft: ftft t.:t::p:la|òÇ:,:. €ftíP .ftft:Spft:Í:t:ft· ftp ftftí X.ft SftPftO 1 P ftp l||;. ft. ftftftiftftftp.: ft:# ftgift X# 10 tftPftPiPPPtS:. ftftft ftftftp. ftíftP Ipft:ft3:ftftftft: ftftftPPft:# s# :ό#®#ό:.®Ρ:θ#Ρ ftftft ftp £ftftftft3J®ft3.ftPft· pftP:ft: EftO ft- p:ft:ftft:a.S .l.iftftdpftftpftftpap >: 35#;:#:®' j. ftS.ptatt ft,. :da:ft;ft: daPe®' :fttO;ft;¥;: :0:1:0453.. dd: 3:. ftpftpftOt :ft:ã:ftâ #5®3θ#ρΡϊί3. '[φΜ i ttO 3;ft53.%d:: Sift®: ft: ftoftt3#3...®:pi®®ft d#: ftftift35fti:ft:i. did· p-ft-dft· ft:a.t
Bft: ftOft: i.ft::s54t.ftda:a:i:# : 333d#:ft:pO:r#:tl:5;i .ftft:# 135p#;p.ftq:t a £:ftft; ft;:i... t. dr:ft.ft®5Cift ft .ρί#®:;#.:#;®::#: |5;®ίΡ:|:::|'.0®5Ρ, :Pft i.:«d:i:ft::i.P;tOft: ·:'ί|ΡΒ #:SiiP3;ft;: dl:®® ft: f€5 .:ft:o M5P:· ft Mftft. PdíftPdPPtPá; ppápi ·#Ρ1: ft# Á XPa ::;aftpft#3.f 3:q:#:p:fts PaPP'f .ip:3.ft:t;·' dft: íiísjríí:1 :pí4:sí::íi:;ív:¾¾¾¾¾: de ©palsdad da aeaa:do ea;;; a Χρρρρρίίρ as; ap eXea;! Ρό;ί.Χρ .daXdP de pad isd $;ροΧρΡΧΡ·Χ add; dad· ..d âsaedy A:;; eaoiaõae scntea, rela 11 eaaeraa ornas da a ouiíòs, de seres da: B-Ι o aaraa: de X.dd: de eeaa: ;Pa pad. dd dada las de aereía da e% a adega: ·χ3© 2X1 em peea: dl XXaXap eeaXea e Pa ©alad da fd% a: apea d;a: dU;l aís pese .de :p0s.:ioX i paddy aedes;· sae pd:i:©X.eaadoe eadeea: iegaedXaaeeao per βρρρρΧρ*: trapepaadedaree ©d eeares; iaereP::ieat;ee: laerteso mae si .prspeagdae das: 3 ap eedaèXa epsi: Pa eyreae dedap ser; eada· Ididlaadda^ d© Idáadeeiaeàéí a sal dá: aaXXpa d : as.laia de. ®M£&amp;> o .Ideede aeatro: á am reXgXXeÉrida: d: d XeaXaX.Xpidp X a f.daPa:tad:i:.lcpXi:í5.a.i Ver s Patent© US X SXdX XX, iaeoxporadc por eerepiaario aadra, para: added Ipeerra;deas sedre adirX as XsrtPaXaaáae.y. PS- ©aaXdaas deeam aer aP:aXTrXaar*jdàa a: XpaXeldyea: par axle .èdPeaaeadaed air gadPiXdadea aàrasada da·: geada de; ide egXkg da ;pesd: earpeeal. a: aerea de XdDU eg/dp :da pera apapdaed.. e., de dpi pdda SíPXXd arda© r Ma,, ded Pese de aerea pé 1;dd maX:.kp; da papa pe rases'1,,, a. aerpa de :kPDd ósseda da pesa aPappeaX.,,; S px;;ef ar I:deí; asesas;© am perlada: da tris: dg a sa ddiras; .ddeârXas :da: Passaei; ;es.maeP, padad aee ddedda;- feXe dadapesa pedam aer: adddaapXdaa aXrgdéi ;da pire Xlapa de aardXs XeXaial aldeada;* aedeXdá da apa á©pea ddád da mesoidPeãeg :!%© eeepple, gp: delsa da; XS: pg/kgia par 2 dares eeapXae: ae 10 p.g/kgSa pr Pd Paaaa. eaPeraa. ppa· desa de S.ãa agi eg ;sa lar;go da dp, parXaPe de. X© eeaaa.* dáa: araaplpa age ee regues, paeparoprse asa ©daXada ρρ©: goarlapa X^ Dl ss: peso da όρΧρΧ.1:οΡ©Ρ:Ρ:©::!Γ: 1*21 apy .peee. de :eaX.at:p: da. sddXa a dSo ad as; jíeae: de Xee faX;ádt.X;aeXX:aa.:. l;.a. i;a.d;X:a;Xdaaa :raeaedXdX;; aas; dota X;eereaeí:;aea da idd: :©;§ de aasia-ia per· ka da gxeea earpexiaX d;era:nt;a: » par Xpds:·; de: V | deeas: <: iffiMgSO 1 .E ιΤΟ'Ρ.ΡίΡ: iiasfô áa Síí-síSí Pig OaO ida agap: |>aaaaiaiiaã aaç
OaiOGaiá dp :ΡΡ|:Ρ}·1ρΡ ν£ίΐ:ΐί!?·: P ipd PST P Pi £££££ ¢#:.1 .ΐΡ:&amp;ίφ&amp; dOaiddP Pd pppid iiPdPidP idP Pp- ipip iPdiapPiaaGadP;*: dal P: ΡρρρΡΡ f Op PPpiip í:SpB!f PPi >Ρ·.;ΡΡ; 10' a . ', .' PPaÓPP4» Pd B:dM:ÒB<b 'ΡΡ,ΡΡ· :P<|:pi|:Ps:£::a:;r :p:Í::p'ptppp:Pt:i;t :P PpsdiPP'P :P:ê ρ:Ρ;ΡΡ. PPSPiiP Pa iPad. add PiOi PdPpidPPPdta Ρρρρ pPPdepliPáid PB; appPif ppil ·ρ· PPppppPp :dp: P.PP â Pud Pi :Pd:iPpia áiiPídP ΐΡΡ dídittdPadP: aPipaP p¥0ppi: S!;Bia.:dPiiap:!;! ap; dalpppp Bp dpPp p 1 a : P dpP ρΡΟ: p PP P|i |.:1 i Pd |ppi ;t P:il::|iK:pSÍ|p <10 aadPPiiPPP· MiMiií Píp êppppi.p BdPP., appal ρρ'ρρρ .pplipipPpki; am. |apj. i\.íp.gá'r at; a.d.>. oaa;GB;;a: ρρββββ:,: Paaa ρρΟιρρο· :!Çpd2,:Xippppat a p;a?;;dapip|p> poms; a lappa: a;aá;ò|H..í. a aptP0B:í! á; .ipaaplp, a. ρρρβρρ, :, " s a ' ' v, a \,\ :** i !>,* o;a"o ' >a P' . a|:; a iilPfe, £p: IJpisipada .aêpadap· dpa; a-.aaaaa.aaass ss 'GéGiaâipa:*: ΟρΙ,Ιρ,ρρρ'Ρ ρ|:. jal>......|fa|||P:f: Pta· paPltapa. Jxlid a· taa appipotppi! apiaapaa Pa TPt p: ISP Pa ρρρρρρρΡρρ; Gap aB-asBp ρρ,Ιορρρ .dpitippaa aPP: paplaa Ρ2ΓΒΡ0 pi:pp.p:i:aap.iap
Tabela I. Sujei tos π a população t:ot:al de LIFOS
ap- Ptaald: il.i Mspaii P I BPS ρρρρρρ-'-ρΡ pap ;ρα|Β-ΐΡΡ:Ρ aBa. poppíá· atitaPPPaS aa· daa.aPP; paPaaaãá: aa tai.IPPpap Pt;
Pd*ΙΟΟοΡΡ , eMMCí! PPfapa-Gsa a ajBai ;pPdP> poaa
:.¥>:·.¥:·.: v.:r.io a/p? a., OiPí i ,. X g/dd o TC 0 40 ag/dP, PPibHDL" :Ρ;ρΒβΡΡρ:ΡΡΡ aP Papoa apB- tttaplp dP;· Iplápj PaPifaaoP descrito, sopre e Hl-L 4 20 og/dP. :(¾¾ PappPPPp Pa: S^“P>!' P P reoatpPa :oa
Bar i.uI xdeda, a di £a uuupa da uoforevi váací a autuo aquelas pua ppappppopi a. ,ρρρίρίο fe PddpPPp: PPP appppaPsdt paaPPPd, d PipppitPald PePaPlPò:'' é 1 — á:p> :ppde: PPp # dia ad atdáipidS'*. P :P ;pU;d|í#U:S:S:S :ΡΡ SSUfeUife:!PIPdlfp' PÉ .dpptp ΟΡΡΡΡίΡΡ:. .¾ fí:«pS tip ppPtlsPP· ρρορρρ s fpppp; plppopp::,
EpPpPa: a /EppPPialp ppldtipp ΡορΙμ· ,ai:Pd dp PPPpsp: 4? PP :ppPP. Pdaa i pdplppispao: .PIÈplp: dal de Piai &amp; IPf Ifa U::S:ufâ:e:t|:daspasaf, ssg drPpPa .fiafP e MplIDd,; siadapdatp PsatÉp dp lasdapald daaaiapa..
EtCEMPPO 2
PpíI-Ipé: ppstaplpd ροΡΡΡΡόΡορ: ups a:uppáps.l.asas :pe áaatidlpppa MPpP sue :dld :apdpbPdpai: s aapdpteasdp sdet |:pdi. spa alp lippapssusspfí: p. fas de paPeaplppp sops alps osopo:sbp:olaM apo oaialalda MfePíp a M:bttDt>: P EpPplp ;p: ÍSSOOOS; POPP: Pp. p;p.i:|.pp:|pp: .plPíM U PpdBEP Splpplppdp, ρίρΡΟΡΟΡΡ PP3pPPPppP;P PPPPS? OPPPpiP® ppp: did ·ρ0ΡΡΡ0Ρ:ΡΡ PdrdlaPà,, :P dlliltddaaa sida- adilaêradd :MM!E: Pa Pifa HPP a apta PtsopPdpà pppPpírpJipoò PP: ip-pPpfPsio PP: da dr 2:f ρ IP, P;P#: rPsps tiloPaPPSP,^ Pm ddPparadâs Pdm Pu Pi spp ppXPPaa da pritBdldae
Tabela S, Subgrupo: sujeitos que nao receberam cortisal i e. t.ra; v e a o s o
Said·: aSSSapaã-áaAS: Aà -AAbaláb SaSb'SSa 1¾¾ aaSASaSaa lie bSSSbl.AlA SA ASa AA AS AaASA paid Α1,1ΜΑ·: AuSAÀa põSS AlAISAx,., CAT: SSfASlASAiS AAAA:SSpb Ái|AÁ&amp;^ A A S aba· S%. EXSHFLO 3
Aa:í:ab,: sfA.liAã. AssAa Apa. εα|ΑαΑΑ®α·ΑΙα ás· IeAIsASasA :S:!AS:a -0:0:¾. .AlA aiãraaa n:|:a.t:ap. slb: Ιαεαε·" §:pddÉ|Átó>: ®s A%a ΑρΑί piAaai. t:ia:er::&amp;p ^feabiE:i:iab:l;a I'uai . pbs:aTbb®b aasaaeAial pa :p:X;e:l;c:ss:f l®::t:ís Λ A, Assaiu· "$;. pastaa assa aspgEapp: pbtlAd p&amp;r aEAAaala: Aa :.AÁs.a::í:Aua.s: aps? xEaSaaia i-:ò:t:rp:~.aÁâcb;i::ba:l. a apasas cp:p:PpaPa -CsASsApaps PSiA basAsa Aspas, ciíbbo-òSbiAlaA: f: pssspppAa absssSpAbi ρ:ρ: pAsispsssstbv. Spsl.j as s.r:ipsssss: lUASA s PASSAS .sAssaSSp. :,SsSsSS:s:APA da. sSaAApaSsa da AS da fv-Sa .a ', ·. ,. ϊ N s a * - -* „ „ b * T&amp;bela 3- Subgrupo ·: sejsites com Bactérias Grain-ífegativas ( Fnsuactfonia Nosocasual ou Pifôloaefrrte
PeiP .Bútepépériigué ide ΟΡόρίΡόο esdélié eeéartPi dd ordiPPttope de Pete lii did sé PE dé: Pt Petà. .StMíl. o ét:éd.OiL:f etáá .feieeedil rctde ;ΕΡοορ:ΐΡ:οό: diliesédids sé 2¾ Pt &amp; ΡίοΡΙί iéépéti iéépsséíé:* A :géééréCiis at; ter Pe r apréseeta. t-s potPdSatee da iteeapdé qte •3 um ué todo oura tratar u repores em. ora ledieòeuo que íi) ideiiifoe· tax Pistil die dipiatiddd de adite deq psede tpd eia r il::> e g/ clip p titi :a:q:tipaf pail, a iptaéég dim, id i sei isédi ria ép.laa:ttsirp:i.. de,» peild: patéda PP eg/dd p ii:papasit.éii:da' dia aéPa diadiétdads ppf paéo aiápqrq 2# pq/ipE# por aoad ai a traça o torra veto a a do seg aísdlapo,;. que ssppsssscld lid tas· toaro 1 ii p i cio, titi), ara ΐρ,ρόρο iqsdtsg e {ddd::P t®t pel dti POpSdp:.,, era .see ee eslegSd pp ,te qpqqo:, ο, .ΕιρρΡίΡΐ.ΧΙρ,ίΡο date prrdépéidp ear edited, de. Sés. a, Pdi eP pppttí s- liiiPuésí pifptrp eu ti: ppeadptp sp céppp de dt a liOt ep pede e o sal de colato está preueste eia ear ca de it a 10t ,ae peed*· es sare. qx.ípppipiad:a: erreis seeds: ipeps trstst a retesada Separed, Pp pasf: ééêdeí.áq s ppo.iéép: ρ sdsd:d:daddaéa deeSsés PP: sssâaáo ee deis dtus, corra qaaetMsdd: see varia dd state. de-iPOPi ;dg/.dt &amp; et st a tip toda eg/lq d,e iteáS: tdiasoeaS,,, é Pairs pt;3f ftrr::eiieid.iiPPPtS de didrou ide: diSp sedias de pdsd eprpdira l. a, Period: die .liSPS edsidf de peed ddismaaal * Pais ,^dé;fd:dép:dáál.dsépd:é:> a, ddiéaqpp. <? addatada P Sdd eg/ida da seat ddrpdsei *. iCt pioddi de ddPtielrPtPBdiíO pede: variara Pd, eaida,, espie· est Pppplptaidedte Pdrrtirdpe de ilsdge dé de: disSespl asdt per iode Se 30530:05, .530" plsto· 55:33:33555:3¾. .3. .31í:3.:05 -ill -ioill 5551: .lolOOO: ifi-l SSiSíSSíf ^ÍÍSlt:<0: -:3- :.155:1.53::5:1^:, l-Osllllll ll 3.5553:55 5::10533503553 3553.53¾¾ "53" 13531:-35.53:3353-, Õlfílllll:;-! SSlli i-OOÍl: ::¾¾¾¾¾¾ , i;l :33lj:l;:|l:l3:, 3 .OllOiS 3:3.33:3313¾ poli, .:¾¾¾¾¾¾¾¾^ OSOliiO 3¾ :OlSO 3 33 3 153531:1 slíí 055; iilllllill 3., 1.0530 3 :3:313:3:301,. 3: 303sl0s?5: 3¾¾ I:53l:3l333t53í3l 43:¾ :0¾¾ .333:¾¾1¾ 1:3.:33:3:33:3: 1::5:::333::--:313:.33:1.3111:3 330 X ' * , O' fj „1 , , - S ' , , '>. 3 ' ’ 33::3333'1:βίί13::1 » :15353:301,115531® 130:555 :33:55 33:5:5¾¾ 3 3: 13:55. 33-1:5::3:1::1¾¾ .3.1:-i:335:5:3í|.>;5l::1.5l3:3 llol. 351:3:3'“ΐ3:®,11::ΐ3θ3:;ί' 3:30555¾ 131:3 33:¾ O :315:1:3:1-51¾ :-53553. :g3lilv· 5Í5s 1:33:3: .Íà:34ll%l3:,3i';|::0ài: #1 :1¾¾¾¾¾ 1¾ 333-11 3 Xi::5i 3: 1:3,3.3 1 53313 O.lõ :1.1:3:1.3 11: 30:3.53::1.53:3 0 13-1 .ill.l 1 111: 1:3 3: 11::115¾¾¾¾¾¾ 311::1,. Q3 :55:555,35:55335- 55; 51; llilíliOl:!! 13:3 :1:3:3335 35S3í:135í:3::3Í:5s: lil :3331¾ 3 OlSll 550055335353- lio: :03:3:0:3:1.11:0: 3 1.1.1 :33:: .1.1 si:! li 0.#ll 53' ÍÉi hl 1:3::3:¾¾¾¾¾¾ : ίο 551 13355 :0o 5:.3153 lOOOÍO.O 1 Olp:i3:03:5le3 c3| 3:301335135 ill llSf 5.311' 3-13:1¾¾ 1:35:5:1:03 Í0:1 .33:::31:13 Oillolilll: 3550.3 t 31 slai ®: 31315:5:3:1¾¾¾ 0-3 .3513¾ 33.3:35:55::33::, .3:35:5:31: ::5300í555:53lO::l:l3:55 03553 I'll: |ífSS 1¾¾¾. 3: 31:35 111 :55:350:1.::11533 llll: .0:¾¾¾ 350 "3l. 13¾¾ 33 sla ,ÍT3ll3ltl

Claims (2)

  1. BE 1VIX CÃÇÔB S iMd.alip dde epyidáeaadd líl ais £dafSiddldOe iiiy dd l.í.aàde ήρρΡΡΟ e :(i:,Í.|:.I Pd :áál. dp ΡρΙΡΡ# pada Xiid dd £χ®®Ρϊ&amp;ΡΡ.£:Ρ ale s p p s 1 e s p e J. a a p ?·: i yy i s t r a c ·;.Ι o i n t; r a v e r o a a a a -y; i n d i v i o u o q p e £ρΡΒρ, idp qp ..pipes d&amp; :S.ÍÍS®|dlpa selde®, difa pala ρρρρρ, 71 p./dlí. e idi aps ,p.p ayaPse #e asa adeel. da pasesipípel dotal da, palp aypdpPi.í dó mg/dp a am alval qa: sigapépteldá dp alda: daagldadp dag palpy apees;* Id meddle· .ρρ®: gdg a -ρρ: :.£pdlvidqd gap gâa agida lei ág pala ayéyddá.# gift Pa® |%1 , 11. idyaaleBP para ppdid.aeçlP dP aPaeydss PP®: a, .gpialodlesaaa l, ed da® a degellda: pmdlsaa Papplgedde x did da aaadd de dOd d. aatdd da diit em peam de :fddf®::xd:pd::sid::f iil] d® :agala; de as a- dada® álé d dl· p® .pdsd: a.P stgidp dpapmg:f. p frid.ll dá áádida: de i: l: a. da add dp: I#l: adi págg da eal ala- dglddd* d*: dsdlala pala qdiaiaagap. de aPeede ae®: a dPl: P i adi dad ma i:?. .e®. qyxadp :pesa:.Pido fPaPdllpiaa a· :dasdati®di®:ai:idyá,. <1 * Emulsão pero uai li yaçdo de acordo com a reivindicação I, em MM o .fe:i®:®ido d ip id e meadas ê; a®; fcdd^ i i pd adáe1- !·.>.. Β®:ρΙ;®£ρ paaa. ρ®11:1®ρ:®ίθ:: da aeaedcy cap a :áeiç:iddi.da:.pl:p !.,> a®, ppdy a msdaeidd sei. aa apiapo: é maleta da .ρρ®1ό·.< :!>> Bmdiaea .paaa.. dt.àl.$.aé:d:ld. xle a::dásdp: ae® .a aeielspliesglg .1.,· gsPSygeaeagpes adaieletee-m a: refaslde apaisâp; aud®. p;pp:Typd::de:da: pee : pae:ia da: Sdfi ®p/:kg: da: pape. .aaapaaal; a. ixddd ay§ ddg da paap d:P:ppa.:ra:a, da pafdxyj,dp a.d.:|aid::P:« ?a ^ddddddd papa, dal:1,ί.ρ.ρρ1;ρ da aepiadp: deá a :.aádyeiyd:SÍi:pdáÍ:a. ρ·ρρρ:ρ®ΡΒ<!ρΒ£;ΐΡ adysladsaraa é:. ypadddlda aasplsl:p: ax.· isaqa de xse: 7xa:aidda. da 71 a.oxa.e.::< 4- > XX ::::35133:3. $341¾. :334-X.X:.33p4:3· 44 .llSlpip ipp: 4 1344434443443 ,Ι;;!! 4.1:-:3:3.041 1 ll 143:444. 333 Xpãl1 :3443 3:P4l44.PX:P3 -4 43 :£:! "S: ·Ώ·. 44444 13¾ Pp.pll; ife f?333. 3.¾¾¾¾1¾ llòl PÍl 31:04 OÓlili. 33 pul isplllm l, 3':.: Js-lXilMl 43:14. -3:41 33: PpiPll 333 3; 143:pX:l4:X33134 1:*· ISl pll1 P:- ::o4J4l.443 ppplXli: piie&amp;pl. 41 lllá: 4. l41>o4ll: "®; 1-3443:3334:144 13:;.. XillXlpl .pp34: plílipppfc 4:3. aillBp- Oil: 4 :331.:3:134:1:3:3:33:3 I,.. :41. 434 3 1:3:3:3:31 4p 3:3:131.3:3 -334 i:i:34443 P;4 4:3P:ipi:i41l3::,. li ,. .Ii3u:l3:â:3 :3333.:33:1.11:33:3:3::3. :43 PlpllO .3:33.. :p: ΙΙ,ΧΐΧΐίΙΙίΡΐΐο1 X,f· :33 111 3 lliPlIlpO 34p4414 4 33:33:3:33. :1103 33C 1:43:,133. 3p:'41p' :3:33313.1:333:^ 111. o 1333..1.:3:4:3 ροΐρ :3:33 4;4 3 4131:3413::3333 1,, 311 3:3.3: 3 .033:331:43: llppilp. 4 plplp-dl ISO 3 13:1 33 1Í35.4 113::33^3:33:1:1.133:3: ,: 13- 144:1.3:4.4 pill: 4:33 43 3.4:3144 33:0: a 334:31:441:.33:34.3- 1> 3:3. 343 4 34:333:-143: 3:4:13:ΐ3:3: .33:434 13. la.oleol.pisla..:, :14:0 BPillfl :p333 P-ll-lalllSl' :1:3 applpo 3.33;: 3 33:13:131:1.33.341: 41. 31. :3:43: 3 plfilllll :1441'3143:4: :33:434 13. 4:4:i443l:lp. :1:31:3:344:13:1 * :13,. .134:1.3:11.1433 :31:.11.14:331:3 33 llPPll » 4:41:33:34:133341 l* 43 4l3:" -1 lldlliol lllllliilo 1:3:143 43' .pill Poll lit.®-::»
  2. 41, Ba3lX..iI:4 4.43¾ ll.lX.illfll' 44 43131:3 111: a. 3'l.l:.3Í::4P:ll4:3:3:3 X.f: 43; 343 1. 33333:llip 34.14:1 ll ill 4-4:313 ll: l«3é: .l:p:f 33I4: llJllil" '313::Q333:4!:3o
PT147108716T 2013-03-15 2014-03-14 Método para tratar sepsies em pacientes com albumina, e níveis de colesterol e hdl acima de um limiar mínimo PT2967138T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13159398 2013-03-15

Publications (1)

Publication Number Publication Date
PT2967138T true PT2967138T (pt) 2018-02-21

Family

ID=47900842

Family Applications (1)

Application Number Title Priority Date Filing Date
PT147108716T PT2967138T (pt) 2013-03-15 2014-03-14 Método para tratar sepsies em pacientes com albumina, e níveis de colesterol e hdl acima de um limiar mínimo

Country Status (23)

Country Link
US (1) US11246998B2 (pt)
EP (1) EP2967138B1 (pt)
JP (1) JP6402415B2 (pt)
KR (1) KR102252629B1 (pt)
CN (1) CN104994757B (pt)
AR (1) AR095306A1 (pt)
AU (1) AU2014230132B2 (pt)
BR (1) BR112015019663B1 (pt)
CA (1) CA2896373C (pt)
ES (1) ES2651129T3 (pt)
IL (1) IL239202B (pt)
MX (1) MX360805B (pt)
MY (1) MY170380A (pt)
NZ (1) NZ709046A (pt)
PH (1) PH12015501203B1 (pt)
PL (1) PL2967138T3 (pt)
PT (1) PT2967138T (pt)
RU (1) RU2653467C2 (pt)
SG (1) SG11201507291XA (pt)
TW (1) TW201446291A (pt)
UA (1) UA116796C2 (pt)
WO (1) WO2014140320A1 (pt)
ZA (1) ZA201503912B (pt)

Families Citing this family (160)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT507187B1 (de) 2008-10-23 2010-03-15 Helmut Dr Buchberger Inhalator
PL2672847T3 (pl) 2011-02-11 2015-10-30 Batmark Ltd Część składowa inhalatora
AT510837B1 (de) 2011-07-27 2012-07-15 Helmut Dr Buchberger Inhalatorkomponente
WO2013034460A1 (en) 2011-09-06 2013-03-14 British American Tobacco (Investments) Limited Heating smokable material
WO2013034459A1 (en) 2011-09-06 2013-03-14 British American Tobacco (Investments) Limited Heating smokeable material
AT511344B1 (de) 2011-10-21 2012-11-15 Helmut Dr Buchberger Inhalatorkomponente
GB201207039D0 (en) 2012-04-23 2012-06-06 British American Tobacco Co Heating smokeable material
GB2504076A (en) 2012-07-16 2014-01-22 Nicoventures Holdings Ltd Electronic smoking device
GB2504075A (en) 2012-07-16 2014-01-22 Nicoventures Holdings Ltd Electronic smoking device
US10314332B2 (en) * 2012-09-10 2019-06-11 Healthier Choices Management, Corp. Electronic vaping material container
GB2513639A (en) 2013-05-02 2014-11-05 Nicoventures Holdings Ltd Electronic cigarette
GB2513638A (en) 2013-05-02 2014-11-05 Nicoventures Holdings Ltd Electronic cigarette
GB2513637A (en) 2013-05-02 2014-11-05 Nicoventures Holdings Ltd Electronic cigarette
GB2514893B (en) 2013-06-04 2017-12-06 Nicoventures Holdings Ltd Container
KR102326709B1 (ko) 2013-09-19 2021-11-17 필립모리스 프로덕츠 에스.에이. 니코틴 염 입자들을 발생시키기 위한 에어로졸 발생 시스템
GB201407426D0 (en) 2014-04-28 2014-06-11 Batmark Ltd Aerosol forming component
RU2672650C2 (ru) * 2014-06-27 2018-11-16 Филип Моррис Продактс С.А. Система, генерирующая аэрозоль, с усовершенствованным прокалывающим элементом
GB2528673B (en) 2014-07-25 2020-07-01 Nicoventures Holdings Ltd Aerosol provision system
EP3000339B1 (en) * 2014-09-23 2017-03-01 Fontem Holdings 1 B.V. Electronic smoking device
WO2016046362A1 (en) * 2014-09-26 2016-03-31 Philip Morris Products S.A. Aerosol-generating system comprising a novel delivery enhancing compound source
EP3200631B1 (en) 2014-10-03 2024-11-06 Philip Morris Products S.A. Electronic nicotine delivery system
EP3009019B1 (en) * 2014-10-17 2019-05-01 Fontem Holdings 1 B.V. Cartridge having a liquid transporting element for uses with an electronic smoking device
GB201418817D0 (en) 2014-10-22 2014-12-03 British American Tobacco Co Apparatus and method for generating an inhalable medium, and a cartridge for use therewith
GB2533135B (en) 2014-12-11 2020-11-11 Nicoventures Holdings Ltd Aerosol provision systems
GB201501429D0 (en) * 2015-01-28 2015-03-11 British American Tobacco Co Apparatus for heating aerosol generating material
EP3253239B1 (en) * 2015-02-06 2020-06-24 Philip Morris Products S.a.s. Containers for aerosol-generating devices
PL229757B1 (pl) * 2015-02-06 2018-08-31 Esmoking Inst Spolka Z Ograniczona Odpowiedzialnoscia Elektroniczne urządzenie do wytwarzania aerozolu, moduł parownika oraz sposób wytwarzania aerozolu
PL3261466T3 (pl) * 2015-02-26 2019-06-28 Philip Morris Products S.A. Pojemniki na urządzenia do wywarzania aerozolu
GB201503411D0 (en) 2015-02-27 2015-04-15 British American Tobacco Co Apparatus and method for generating an inhalable medium, and a cartridge for use therewith
JP6701218B2 (ja) 2015-03-27 2020-05-27 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム バイメタルストリップを備えるエアロゾル発生システム
US10994085B2 (en) 2015-03-27 2021-05-04 Philip Morris Products S.A. Aerosol-generating system comprising integrated piercing element
KR102601370B1 (ko) 2015-03-27 2023-11-13 필립모리스 프로덕츠 에스.에이. 재밀봉 가능한 에어로졸 발생 물품
US10806873B2 (en) * 2015-03-27 2020-10-20 Philip Morris Products S.A. Aerosol-generating system comprising a resilient member
RU2692786C2 (ru) 2015-03-27 2019-06-27 Филип Моррис Продактс С.А. Система, генерирующая аэрозоль, содержащая разрывающую часть
GB201505595D0 (en) 2015-03-31 2015-05-13 British American Tobacco Co Cartridge for use with apparatus for heating smokeable material
GB201505597D0 (en) 2015-03-31 2015-05-13 British American Tobacco Co Article for use with apparatus for heating smokable material
US11033692B2 (en) * 2015-04-15 2021-06-15 Philip Morris Products S.A. Flavoring element for an inhalation device
CN107529832B (zh) * 2015-05-01 2021-07-20 日本烟草产业株式会社 非燃烧型香味抽吸器、香吸味源单元及雾化单元
GB201508405D0 (en) 2015-05-15 2015-07-01 British American Tobacco Co Article and apparatus for generating an aerosol
US10328443B2 (en) 2015-06-29 2019-06-25 Philip Morris Products S.A. Cartridge for an aerosol-generating system
GB201511361D0 (en) * 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic vapour provision system
GB201511359D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic vapour provision system
GB201511358D0 (en) * 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic aerosol provision systems
GB201511349D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic aerosol provision systems
CN105167198B (zh) * 2015-07-23 2018-07-24 云南中烟工业有限责任公司 一种平层分布式多温区电子烟
JP6866314B2 (ja) 2015-08-17 2021-04-28 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム エアロゾル発生システムおよびそのシステムにおける使用のためのエアロゾル発生物品
ES2742518T3 (es) 2015-08-17 2020-02-14 Philip Morris Products Sa Sistema generador de aerosol y artículo generador de aerosol para usar en dicho sistema
WO2017029268A1 (en) 2015-08-17 2017-02-23 Philip Morris Products S.A. Aerosol-generating system and aerosol-generating article for use in such a system
US20170055584A1 (en) 2015-08-31 2017-03-02 British American Tobacco (Investments) Limited Article for use with apparatus for heating smokable material
US11924930B2 (en) 2015-08-31 2024-03-05 Nicoventures Trading Limited Article for use with apparatus for heating smokable material
US20170055574A1 (en) 2015-08-31 2017-03-02 British American Tobacco (Investments) Limited Cartridge for use with apparatus for heating smokable material
JP6812420B2 (ja) * 2015-09-11 2021-01-13 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム カートリッジおよびカートリッジを含むエアロゾル形成物品のためのシステム
GB2542838B (en) 2015-10-01 2022-01-12 Nicoventures Trading Ltd Aerosol provision system
GB201517471D0 (en) 2015-10-02 2015-11-18 British American Tobacco Co Apparatus for generating an inhalable medium
US20170119050A1 (en) 2015-10-30 2017-05-04 British American Tobacco (Investments) Limited Article for Use with Apparatus for Heating Smokable Material
US20170119051A1 (en) 2015-10-30 2017-05-04 British American Tobacco (Investments) Limited Article for Use with Apparatus for Heating Smokable Material
US20180317554A1 (en) 2015-10-30 2018-11-08 British American Tobacco (Investments) Limited Article for use with apparatus for heating smokable material
US20170119046A1 (en) 2015-10-30 2017-05-04 British American Tobacco (Investments) Limited Apparatus for Heating Smokable Material
CN118319062A (zh) * 2015-12-21 2024-07-12 菲利普莫里斯生产公司 包括可变空气入口的气溶胶生成系统
CN108430550B (zh) * 2016-01-25 2021-03-16 菲利普莫里斯生产公司 具有致动部分的筒组合件
CA3007764A1 (en) * 2016-02-01 2017-08-10 Philip Morris Products S.A. Aerosol-generating device having multiple power supplies
US12356507B2 (en) 2016-02-01 2025-07-08 Altria Client Services Llc Aerosol-generating device having multiple power supplies
US10433580B2 (en) 2016-03-03 2019-10-08 Altria Client Services Llc Methods to add menthol, botanic materials, and/or non-botanic materials to a cartridge, and/or an electronic vaping device including the cartridge
US10455863B2 (en) 2016-03-03 2019-10-29 Altria Client Services Llc Cartridge for electronic vaping device
US10368580B2 (en) 2016-03-08 2019-08-06 Altria Client Services Llc Combined cartridge for electronic vaping device
US10368581B2 (en) 2016-03-11 2019-08-06 Altria Client Services Llc Multiple dispersion generator e-vaping device
US20170258140A1 (en) 2016-03-11 2017-09-14 Altria Client Services Llc Multiple dispersion generator e-vaping device
US10357060B2 (en) 2016-03-11 2019-07-23 Altria Client Services Llc E-vaping device cartridge holder
US10631572B2 (en) 2016-03-31 2020-04-28 Altria Client Services Llc Aerosol-generating system with separate capsule and vaporizing unit
EP4309715A3 (en) 2016-04-27 2024-03-27 Nicoventures Trading Limited Electronic aerosol provision system and vaporizer therefor
JP6874020B2 (ja) * 2016-04-28 2021-05-19 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム エアロゾル発生システムで使用するための結合要素を備えるカートリッジ
GB201607475D0 (en) 2016-04-29 2016-06-15 British American Tobacco Co Article for generating an inhalable medium and method of heating a smokable material
GB201607474D0 (en) 2016-04-29 2016-06-15 British American Tobacco Co Article, apparatus and method of heating a smokable material
EP4245177A3 (en) 2016-05-13 2024-05-15 Nicoventures Trading Limited Apparatus arranged to heat smokable material and method of forming a heater
TW201742554A (zh) 2016-05-13 2017-12-16 英美煙草（投資）有限公司 用於容收可吸菸材料之裝置
CN109152893B (zh) * 2016-05-31 2021-07-20 菲利普莫里斯生产公司 具有一体式加热器组件的气溶胶生成装置
WO2018002086A1 (en) * 2016-06-29 2018-01-04 British American Tobacco (Investments) Limited Apparatus for heating smokable material
KR102664257B1 (ko) * 2016-06-29 2024-05-10 니코벤처스 트레이딩 리미티드 흡연가능 물질을 가열하기 위한 장치
CA3028019C (en) 2016-06-29 2021-05-25 British American Tobacco (Investments) Limited Apparatus for heating smokable material
US10791760B2 (en) 2016-07-29 2020-10-06 Altria Client Services Llc Aerosol-generating system including a cartridge containing a gel
PL3490390T3 (pl) 2016-07-29 2024-07-01 Philip Morris Products S.A. Układ wytwarzania aerozolu zawierający wkład zawierający żel
DE102016114718B4 (de) * 2016-08-09 2021-02-25 Hauni Maschinenbau Gmbh Inhalator
GB201618481D0 (en) 2016-11-02 2016-12-14 British American Tobacco Investments Ltd Aerosol provision article
RU2728529C1 (ru) * 2017-01-25 2020-07-30 Бритиш Америкэн Тобэкко (Инвестментс) Лимитед Устройство для нагревания курительного материала
GB201702206D0 (en) 2017-02-10 2017-03-29 British American Tobacco Investments Ltd Vapour provision system
WO2018183492A1 (en) * 2017-03-28 2018-10-04 Advanced Grow Labs Technologies, Llc Vaporizing device system and method
CN206808677U (zh) * 2017-05-10 2017-12-29 深圳市合元科技有限公司 可温度校准的电磁加热电子烟
EP3651839B1 (en) * 2017-07-10 2021-04-07 Philip Morris Products S.a.s. A cartridge assembly with ventilation airflow for an aerosol-generating system
ES2946435T3 (es) * 2017-08-09 2023-07-18 Philip Morris Products Sa Dispositivo generador de aerosol con calentador de inducción modular
CN111093408A (zh) 2017-09-15 2020-05-01 英美烟草(投资)有限公司 用于加热可抽吸材料的设备
CN109924544A (zh) * 2017-12-18 2019-06-25 深圳市赛尔美电子科技有限公司 烟具及其控制方法
GB201721447D0 (en) 2017-12-20 2018-01-31 British American Tobacco Investments Ltd Electronic aerosol provision system
GB201721470D0 (en) 2017-12-20 2018-01-31 British American Tobacco Investments Ltd Electronic aerosol provision system
GB201721477D0 (en) 2017-12-20 2018-01-31 British American Tobacco Investments Ltd Electronic aerosol provision system
KR102343888B1 (ko) 2018-01-31 2021-12-27 주식회사 케이티앤지 에어로졸 발생 시스템
JP7031342B2 (ja) * 2018-02-09 2022-03-08 凸版印刷株式会社 噴霧器
US20210046041A1 (en) * 2018-03-06 2021-02-18 Canopy Growth Corporation Device and method for administering an active ingredient
US12102118B2 (en) 2018-03-09 2024-10-01 Rai Strategic Holdings, Inc. Electronically heated heat-not-burn smoking article
GB201808526D0 (en) * 2018-05-24 2018-07-11 Nicoventures Trading Ltd Aerosol Generation
WO2019234055A1 (en) 2018-06-05 2019-12-12 Philip Morris Products S.A. Cartridge assembly with activating piercing members for an aerosol-generating system
WO2019238704A1 (en) * 2018-06-12 2019-12-19 Philip Morris Products S.A. Aerosol generating system with heated mixing chamber
WO2020002671A1 (en) 2018-06-29 2020-01-02 Philip Morris Products S.A. A cartridge for an aerosol-generating system
EP3813577B1 (en) * 2018-06-29 2022-02-16 Philip Morris Products S.A. Aerosol generating system with enhanced aerosol delivery
US12310414B2 (en) 2018-07-06 2025-05-27 Philip Morris Products S.A. Aerosol-generating device with adaptable haptic feedback
WO2020020951A1 (en) * 2018-07-26 2020-01-30 Philip Morris Products S.A. System for generating an aerosol
GB201812373D0 (en) 2018-07-30 2018-09-12 Nicoventures Trading Ltd Generation of an inhalable medium
WO2020025746A1 (en) * 2018-08-02 2020-02-06 Philip Morris Products S.A. System comprising aerosol-generating device and adapter element
CN112638187A (zh) * 2018-08-24 2021-04-09 日本烟草产业株式会社 吸取成分生成装置、控制吸取成分生成装置的方法以及程序
KR102467836B1 (ko) 2018-10-30 2022-11-16 주식회사 케이티앤지 에어로졸 발생 물품 및 그를 포함하는 에어로졸 발생 장치
GB201817860D0 (en) 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolised formulation
KR102194730B1 (ko) * 2018-11-16 2020-12-23 주식회사 케이티앤지 제1히터 및 제2히터를 갖는 에어로졸 생성장치 및 에어로졸 생성장치의 제1히터 및 제2히터의 전력을 제어하는 방법
GB201818711D0 (en) 2018-11-16 2019-01-02 Nicoventures Trading Ltd Method
KR102194731B1 (ko) * 2018-11-16 2020-12-23 주식회사 케이티앤지 하나의 배터리로 두 개의 히터들에 전력을 공급하는 에어로졸 생성 장치
KR102199793B1 (ko) * 2018-12-11 2021-01-07 주식회사 케이티앤지 에어로졸 생성 장치
CA3124606C (en) 2019-01-04 2023-10-10 Nicoventures Trading Limited Aerosol generation
WO2020153829A1 (ko) * 2019-01-24 2020-07-30 주식회사 이엠텍 전기 가열식 흡연 물품 내에 삽입될 수 있는 겔상 에어로졸 발생기질 카트리지, 이를 포함하는 전기 가열식 흡연 물품 및 이를 위한 에어로졸 발생 장치 및 시스템
WO2020153828A1 (ko) * 2019-01-24 2020-07-30 주식회사 이엠텍 전기 가열식 흡연 물품 내에 삽입될 수 있는 액상 카트리지, 이를 포함하는 전기 가열식 흡연 물품 및 이를 위한 에어로졸 발생 장치 및 시스템
CN113796160A (zh) * 2019-04-29 2021-12-14 音诺艾迪有限公司 复合加热型烟雾生成装置
KR102652571B1 (ko) * 2019-04-29 2024-03-29 주식회사 이노아이티 복합 히팅 에어로졸 발생장치
US20230346025A1 (en) * 2019-04-29 2023-11-02 Inno-It Co., Ltd. Complex Heating Type Aerosol Generating Device
KR102178416B1 (ko) * 2019-05-17 2020-11-13 주식회사 이엠텍 마이크로웨이브 가열장치
KR102178419B1 (ko) * 2019-05-20 2020-11-13 주식회사 이엠텍 마이크로웨이브 가열장치
IL288438B2 (en) 2019-06-05 2025-05-01 Philip Morris Products Sa Spray generating device with heat conducting assembly
KR102337229B1 (ko) 2019-08-05 2021-12-08 주식회사 케이티앤지 에어로졸 생성 장치 및 이를 포함하는 에어로졸 생성 시스템
GB201917454D0 (en) 2019-11-29 2020-01-15 Nicoventures Trading Ltd Electronic aerosol provision system
GB201917479D0 (en) * 2019-11-29 2020-01-15 Nicoventures Trading Ltd Electronic aerosol provision system
KR20210073372A (ko) 2019-12-10 2021-06-18 주식회사 케이티앤지 에어로졸 생성 시스템
KR102330310B1 (ko) 2019-12-27 2021-11-24 주식회사 케이티앤지 모드에 따라 시각적으로 다른 증기를 배출하는 에어로졸 생성 장치
WO2021141290A1 (en) * 2020-01-06 2021-07-15 Kt&G Corporation Aerosol generating device
KR102354664B1 (ko) * 2020-01-07 2022-01-24 제이디코스파마 주식회사 약제 흡입기
KR102408932B1 (ko) * 2020-02-14 2022-06-14 주식회사 케이티앤지 에어로졸 생성 장치 및 에어로졸 생성 시스템
KR102479092B1 (ko) 2020-02-24 2022-12-19 주식회사 케이티앤지 에어로졸 생성 장치
KR102478152B1 (ko) * 2020-03-02 2022-12-15 주식회사 케이티앤지 에어로졸 생성 장치 및 에어로졸 생성 시스템
US12484610B2 (en) * 2020-04-16 2025-12-02 R.J. Reynolds Tobacco Company Aerosol delivery device including a segregated substrate
IL312785A (en) 2020-05-19 2024-07-01 Cybin Irl Ltd Denatured Tryptamine Derivatives and Methods of Use
KR102420393B1 (ko) * 2020-05-28 2022-07-13 제이디코스파마 주식회사 약제 기화 흡입기
KR102512072B1 (ko) * 2020-10-16 2023-03-20 주식회사 케이티앤지 에어로졸 생성 물품 및 이를 가열하기 위한 에어로졸 생성 장치
KR102487085B1 (ko) 2020-10-19 2023-01-10 주식회사 케이티앤지 에어로졸 생성 물품 및 이를 포함하는 에어로졸 생성 시스템
KR102647379B1 (ko) * 2020-10-19 2024-03-13 주식회사 케이티앤지 유기 산을 포함하는 에어로졸 생성 물품
USD990765S1 (en) 2020-10-30 2023-06-27 Nicoventures Trading Limited Aerosol generator
JP1714440S (ja) 2020-10-30 2022-05-10 喫煙用エアロゾル発生器
JP1715888S (ja) 2020-10-30 2022-05-25 喫煙用エアロゾル発生器
JP1714442S (ja) 2020-10-30 2022-05-10 喫煙用エアロゾル発生器
JP1714441S (ja) 2020-10-30 2022-05-10 喫煙用エアロゾル発生器
JP1714443S (ja) 2020-10-30 2022-05-10 喫煙用エアロゾル発生器
KR102675541B1 (ko) 2020-11-10 2024-06-17 주식회사 케이티앤지 에어로졸 생성 물품 및 이를 포함하는 에어로졸 생성 시스템
EP4262446B1 (en) * 2020-12-17 2024-09-18 Philip Morris Products S.A. Capsule with susceptor particles and carrier
KR102630397B1 (ko) * 2021-04-16 2024-01-29 주식회사 케이티앤지 차등 가열 기능을 구비한 에어로졸 발생 장치 및 이에 적용되는 에어로졸 발생 물품
USD989384S1 (en) 2021-04-30 2023-06-13 Nicoventures Trading Limited Aerosol generator
KR102625768B1 (ko) * 2021-06-14 2024-01-16 주식회사 케이티앤지 에어로졸 생성 장치 및 그 제어 방법
KR20230052172A (ko) * 2021-10-12 2023-04-19 주식회사 이노아이티 에어로졸 발생장치용 금속섬유 면상발열 히터
US20240398028A1 (en) * 2021-10-19 2024-12-05 Kt&G Corporation Aerosol generating device
KR102862255B1 (ko) * 2021-10-19 2025-09-22 주식회사 케이티앤지 에어로졸 생성장치
KR102693883B1 (ko) * 2021-10-28 2024-08-08 주식회사 케이티앤지 복수의 히터를 구비한 에어로졸 발생 장치 및 이와 함께 사용되는 에어로졸 발생 물품
JP7698131B2 (ja) * 2021-11-11 2025-06-24 ケーティー アンド ジー コーポレイション エアロゾル生成装置
KR102737189B1 (ko) * 2021-12-28 2024-12-03 주식회사 케이티앤지 에어로졸 발생 장치 및 이를 포함하는 시스템
GB202200793D0 (en) * 2022-01-21 2022-03-09 Nicoventures Trading Ltd Aerosol provision system
WO2023170733A1 (ja) * 2022-03-07 2023-09-14 日本たばこ産業株式会社 エアロゾル発生システム及びエアロゾル発生装置
KR102807293B1 (ko) * 2022-03-21 2025-05-16 주식회사 이엠텍 다중 발열부를 선택적으로 가열하는 에어로졸 발생 장치
KR102807216B1 (ko) * 2023-04-24 2025-05-16 주식회사 이노아이티 에어로졸 발생장치

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093894A (en) * 1989-12-01 1992-03-03 Philip Morris Incorporated Electrically-powered linear heating element
US5249586A (en) * 1991-03-11 1993-10-05 Philip Morris Incorporated Electrical smoking
US6234167B1 (en) * 1998-10-14 2001-05-22 Chrysalis Technologies, Incorporated Aerosol generator and methods of making and using an aerosol generator
AU2003284199B2 (en) * 2002-10-31 2009-12-17 Philip Morris Products S.A. Electrically heated cigarette including controlled-release flavoring
US7234470B2 (en) 2003-08-28 2007-06-26 Philip Morris Usa Inc. Electromagnetic mechanism for positioning heater blades of an electrically heated cigarette smoking system
US8322350B2 (en) 2004-12-30 2012-12-04 Philip Morris Usa Inc. Aerosol generator
CN201067079Y (zh) 2006-05-16 2008-06-04 韩力 仿真气溶胶吸入器
AU2008232897B2 (en) * 2007-03-30 2014-03-13 Philip Morris Products Sa Device and method for delivery of a medicament
US20090293888A1 (en) * 2008-05-30 2009-12-03 Vapor For Life Portable vaporizer for plant material
UA105038C2 (uk) 2009-03-17 2014-04-10 Філіп Морріс Продактс С.А. Система для утворення аерозолю нікотину, одержаного з тютюну
DE102009029768B4 (de) 2009-06-18 2013-02-21 Zetzig Ab Vorrichtung zur Abgabe von Nikotin
MY163517A (en) 2009-09-16 2017-09-15 Philip Morris Products Sa Improved device and method for delivery of a medicament
EP2327318A1 (en) * 2009-11-27 2011-06-01 Philip Morris Products S.A. An electrically heated smoking system with internal or external heater
EP2340729A1 (en) 2009-12-30 2011-07-06 Philip Morris Products S.A. An improved heater for an electrically heated aerosol generating system
CN101822420B (zh) * 2010-04-22 2012-06-27 修运强 一种组合式多功能电子模拟香烟
HRP20211529T1 (hr) 2010-08-24 2021-12-24 Jt International S.A. Uređaj za udisanje koji uključuje kontrole za upotrebu tvari
EP2468117A1 (en) * 2010-12-24 2012-06-27 Philip Morris Products S.A. An aerosol generating system having means for determining depletion of a liquid substrate
RU103281U1 (ru) 2010-12-27 2011-04-10 Общество с ограниченной ответственностью "ПромКапитал" Электронная сигарета
US20130014755A1 (en) * 2011-07-11 2013-01-17 Jay Kumar Vaporization device
WO2013034460A1 (en) * 2011-09-06 2013-03-14 British American Tobacco (Investments) Limited Heating smokable material
WO2013034459A1 (en) 2011-09-06 2013-03-14 British American Tobacco (Investments) Limited Heating smokeable material
BR112014009862A2 (pt) 2011-10-25 2017-04-18 Philip Morris Products Sa dispositivo gerador de aerossol com um conjunto de aquecedor
UA78167U (uk) 2012-09-05 2013-03-11 Евгений Владимирович Балюра Одноразова електронна сигарета

Also Published As

Publication number Publication date
JP2016516402A (ja) 2016-06-09
UA116796C2 (uk) 2018-05-10
MX360805B (es) 2018-11-16
IL239202B (en) 2019-09-26
BR112015019663B1 (pt) 2021-05-18
MX2015013052A (es) 2016-09-07
RU2015144036A3 (pt) 2018-03-06
NZ709046A (en) 2019-01-25
RU2015144036A (ru) 2017-04-27
JP6402415B2 (ja) 2018-10-10
PL2967138T3 (pl) 2018-03-30
US20160022930A1 (en) 2016-01-28
ES2651129T3 (es) 2018-01-24
KR20150129683A (ko) 2015-11-20
AR095306A1 (es) 2015-10-07
TW201446291A (zh) 2014-12-16
PH12015501203A1 (en) 2015-08-17
EP2967138A1 (en) 2016-01-20
US11246998B2 (en) 2022-02-15
AU2014230132A1 (en) 2015-10-29
CN104994757A (zh) 2015-10-21
PH12015501203B1 (en) 2020-10-21
EP2967138B1 (en) 2017-11-22
CA2896373C (en) 2021-09-14
CN104994757B (zh) 2018-05-18
AU2014230132B2 (en) 2018-03-08
SG11201507291XA (en) 2015-10-29
RU2653467C2 (ru) 2018-05-08
CA2896373A1 (en) 2014-09-18
KR102252629B1 (ko) 2021-05-20
MY170380A (en) 2019-07-26
ZA201503912B (en) 2016-04-28
WO2014140320A1 (en) 2014-09-18
HK1214927A1 (en) 2016-08-12
IL239202A0 (en) 2015-07-30
BR112015019663A2 (pt) 2017-07-18

Similar Documents

Publication Publication Date Title
PT2967138T (pt) Método para tratar sepsies em pacientes com albumina, e níveis de colesterol e hdl acima de um limiar mínimo
Rensen et al. Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting
Yu et al. The effect of various absorption enhancers on tight junction in the human intestinal Caco-2 cell line
Pinkney et al. Should surgeons treat diabetes in severely obese people?
Hunter Loneliness: a public health issue
Schlüter et al. Arylmethyl substituted derivatives of fosmidomycin: synthesis and antimalarial activity
Khan et al. Recurrent spontaneous esophageal rupture
Belmin et al. Confinement of staff with residents in nursing homes: a solution against COVID-19?
Mbelesso et al. Représentations socioculturelles de l’épilepsie en milieu scolaire à Bangui en République centrafricaine
Takken et al. Ecology and control of vector-borne diseases
Catalucci Cardio Ultraefficient nanoParticles for Inhalation of Drug prOducts: when CUPIDO hits the nano-revolution in cardiology
Dunić et al. Patients’ reported quality of life in chronic venous disease in an outpatient service in Belgrade, Serbia
Alonso et al. Expansion of the intraepithelial lymphocyte (IEL) compartment results in an increased bioenergetic profile and reduced IFNγ production in γδ IELs
Yacoub et al. La lymphangite carcinomateuse digestive
Dupuy et al. Understanding the evolution of polydnaviruses
Mukherjea Tobacco industry co-optation of culture? Converging culturally specific and mainstream tobacco products in India
Vautier et al. ABCB1 (P-glycoprotein) and blood-brain barrier: role in neurological diseases and their treatments
Roru Stigmas and obstacles in communicable disease research: Responses to the Herpes Simplex Virus
Robson ‘On demand’drugs deliver only when needed
Kernan et al. Defibrotide for the treatment of patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome with/without multi-organ dysfunction following chemotherapy: results from an ongoing expanded access program
Perea Commentary on vocal and verbal body symptoms. Pathological fracture of ordinary behaviour
Brunie et al. Everolimus position after pulmonary transplantation: a pediatric case-report
Danel et al. The physical health of the persons suffering from schizophrenia: implication of the device of psychiatric care
Rapaka et al. Evolution of antibody responses against carbohydrate and protein antigens of Pneumocystis carinii: Implications for antibody-based vaccine protection (51.12)
Abessolo et al. Vitamin a in Gabonese children not receiving supplements: relation to ocular and nutritional diseases